Karmanos Cancer Institute (126)

Detroit, Michigan 48201

0 studies enrolling now · 1 studies all time

What they study most

Solid Tumor, Adult

Studies at this site

• First-in-human Study of IO-108 as Single Agent and in Combination With a PD-1 Immune Check Point Inhibitor in Patients With Advanced Solid Tumors — Completed